Keywords: update, celebrex, vioxx, panel, review, cox-2, inhibitors

Update - Celebrex and Vioxx panel review on COX-2 inhibitors

Article | 15 February 2001

Print This

As reported briefly in the Marketletter last week, a US Food and DrugAdministration advisory panel has declined to recommend approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in